Cell surface protein glycosylation in cancer

Glycosylation of proteins is one of the most important PTMs, with more than half of all human proteins estimated to be glycosylated. It is widely known that aberrant glycosylation has been implicated in many different diseases due to changes associated with biological function and protein folding. In cancer, there is increasing evidence pertaining to the role of glycosylation in tumour formation and metastasis. Alterations in cell surface glycosylation, particularly terminal motifs, can promote invasive behaviour of tumour cells that ultimately lead to the progression of cancer. While a majority of studies have investigated protein glycosylation changes in cancer cell lines and tumour tissue for individual cancers, the review presented here represents a comprehensive, in‐depth overview of literature on the structural changes of glycosylation and their associated synthetic enzymes in five different cancer types originating from the breast, colon, liver, skin and ovary. More importantly, this review focuses on key similarities and differences between these cancers that reflect the importance of structural changes of cell surface N‐ and O‐glycans, such as sialylation, fucosylation, degree of branching and the expression of specific glycosyltransferases for each cancer. It is envisioned that the understanding of these biologically relevant glycan alterations on cellular proteins will facilitate the discovery of novel glycan‐based biomarkers which could potentially serve as diagnostic and prognostic indicators of cancer.

[1]  M. Dietel Discrimination between benign, borderline, and malignant epithelial ovarian tumors using tumor markers: an immunohistochemical study. , 1983, Cancer detection and prevention.

[2]  C. Cordon-Cardo,et al.  Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines. , 1986, Cancer research.

[3]  A. Thor,et al.  Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. , 1986, Cancer research.

[4]  T. Chen,et al.  WiDr is a derivative of another colon adenocarcinoma cell line, HT-29. , 1987, Cancer genetics and cytogenetics.

[5]  R. Kerbel,et al.  Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. , 1987, Science.

[6]  Y. Kim,et al.  Characterization of quantitative mucin variants from a human colon cancer cell line. , 1987, Cancer research.

[7]  M. Herlyn,et al.  Presence of tumor-associated antigens in epidermal growth factor receptors from different human carcinomas. , 1987, Cancer research.

[8]  A. Passaniti,et al.  Cell surface sialylation and tumor metastasis. Metastatic potential of B16 melanoma variants correlates with their relative numbers of specific penultimate oligosaccharide structures. , 1988, The Journal of biological chemistry.

[9]  S. Fujii,et al.  N-acetylglucosaminyltransferase III in human serum, and liver and hepatoma tissues: increased activity in liver cirrhosis and hepatoma patients. , 1989, Clinica chimica acta; international journal of clinical chemistry.

[10]  J. Dennis,et al.  Oncodevelopmental Expression of —GlcNAcβ1–6Manα1-6Manβ1— Branched Asparagine-linked Oligosaccharides in Murine Tissues and Human Breast Carcinomas , 1989 .

[11]  Y. Kim,et al.  Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. , 1989, Cancer research.

[12]  S. Hakomori,et al.  Sialosyl‐Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients , 1990, Cancer.

[13]  J. Vredenburgh,et al.  Reactivity of anti-CD15 monoclonal antibody PM-81 with breast cancer and elimination of breast cancer cells from human bone marrow by PM-81 and immunomagnetic beads. , 1991, Cancer research.

[14]  M. Inoue,et al.  Expression of Tn and sialyl-Tn antigens in tumor tissues of the ovary. , 1991, American journal of clinical pathology.

[15]  J. Dennis,et al.  Beta 1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. , 1991, Cancer research.

[16]  R. Dahiya,et al.  Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis. , 1991, The Journal of clinical investigation.

[17]  A. Kobata,et al.  N-linked sugar chains of mouse B16 melanoma cells and their low-metastasizing variant selected by wheat germ agglutinin. , 1991, Glycobiology.

[18]  M. Du,et al.  Fucosyltransferases: Differential plasma and tissue alterations in hepatocellular carcinoma and cirrhosis , 1991, Hepatology.

[19]  S. Thung,et al.  Expression of sialylated Lewis(x) antigen in chronic and neoplastic liver diseases. , 1992, Archives of pathology & laboratory medicine.

[20]  R. Dahiya,et al.  Mucin synthesis and secretion in relation to spontaneous differentiation of colon cancer cells in vitro , 1992, International journal of cancer.

[21]  H. Kobayashi,et al.  Sialyl Tn as a prognostic marker in epithelial ovarian cancer. , 1992, British Journal of Cancer.

[22]  M. Herlyn,et al.  Quantitative dot blot analyses of blood‐group‐related antigens in paired normal and malignant human breast tissues , 1992, International journal of cancer.

[23]  K. Tanikawa,et al.  A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma. , 1993, Cancer research.

[24]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.

[25]  R. Kannagi,et al.  Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. , 1993, Cancer research.

[26]  T. Irimura,et al.  Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. , 1993, Cancer research.

[27]  J. Sakamoto,et al.  Association of expression of blood group‐related carbohydrate antigens with prognosis in breast cancer , 1993, Cancer.

[28]  A. Varki,et al.  Biological roles of oligosaccharides: all of the theories are correct , 1993, Glycobiology.

[29]  Immunohistochemical evaluation of sialosyl-Tn antigens in various ovarian carcinomas. , 1993, Gynecologic oncology.

[30]  W. Gregory,et al.  Expression of sialyl-Tn predicts the effect of adjuvant chemotherapy in node-positive breast cancer. , 1994, British Journal of Cancer.

[31]  S. Itzkowitz,et al.  Use of model cell lines to study the biosynthesis and biological role of cancer-associated sialosyl-Tn antigen. , 1994, Cancer Research.

[32]  Y. Chung,et al.  Alterations of O-glycan biosynthesis in human colon cancer tissues. , 1994, Glycobiology.

[33]  Y. Kim,et al.  Immunohistochemical study of mucin carbohydrates and core proteins in human ovarian tumors. , 1994, Human pathology.

[34]  I. Brockhausen,et al.  O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer. , 1994, European journal of biochemistry.

[35]  I. Finnie,et al.  Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin. , 1995, The Journal of clinical investigation.

[36]  I. Brockhausen,et al.  Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. , 1995, European journal of biochemistry.

[37]  F. Schmitt,et al.  Expression of sialyl-Tn in breast cancer. Correlation with prognostic parameters. , 1996, Pathology, research and practice.

[38]  T. Araki,et al.  Tn and sialyl-Tn antigens as potential prognostic markers in human ovarian carcinoma. , 1996, Gynecologic and obstetric investigation.

[39]  B. Yin,et al.  Serological and immunochemical analysis of Lewis Y (Ley) blood group antigen expression in epithelial ovarian cancer , 1996, International journal of cancer.

[40]  Y. Matsuzawa,et al.  Aberrant Glycosylation of E-cadherin Enhances Cell-Cell Binding to Suppress Metastasis* , 1996, The Journal of Biological Chemistry.

[41]  N. Kedersha,et al.  Unique alpha 2, 8-polysialylated glycoproteins in breast cancer and leukemia cells. , 1996, Glycobiology.

[42]  S. Tsuji,et al.  Molecular cloning and functional analysis of sialyltransferases. , 1996, Journal of biochemistry.

[43]  N. Kedersha,et al.  Unique α2, 8-polysialylated glycoproteins in breast cancer and leukemia cells , 1996 .

[44]  J. Taylor‐Papadimitriou,et al.  Comparison of O-Linked Carbohydrate Chains in MUC-1 Mucin from Normal Breast Epithelial Cell Lines and Breast Carcinoma Cell Lines: , 1996, The Journal of Biological Chemistry.

[45]  Y. Kim,et al.  Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis. , 1996, Gastroenterology.

[46]  R. Kannagi,et al.  Altered mRNA expression of specific molecular species of fucosyl‐ and sialyl‐transferases in human colorectal cancer tissues , 1997, International journal of cancer.

[47]  E. Gorelik,et al.  Reduction of metastatic properties of BL6 melanoma cells expressing terminal fucose(alpha)1-2-galactose after alpha1,2-fucosyltransferase cDNA transfection. , 1997, Cancer research.

[48]  T. Paavonen,et al.  Endothelial and epithelial expression of sialyl Lewisx and sialyl Lewisa in lesions of breast carcinoma , 1997, International journal of cancer.

[49]  T. Irimura,et al.  Involvement of carbohydrate antigen sialyl Lewisx in colorectal cancer metastasis , 1997, Diseases of the colon and rectum.

[50]  D L Morton,et al.  Endothelial‐selectin ligands sialyl Lewisx and sialyl Lewisa are differentiation antigens immunogenic in human melanoma , 1997, Cancer.

[51]  L. Hornez,et al.  Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. , 1998, Cancer research.

[52]  R. Bresalier,et al.  Liver metastasis and adhesion to the sinusoidal endothelium by human colon cancer cells is related to mucin carbohydrate chain length , 1998, International journal of cancer.

[53]  R. Kannagi,et al.  Gene expression of fucosyl- and sialyl-transferases which synthesize sialyl Lewisx, the carbohydrate ligands for E-selectin, in human breast cancer. , 1998, International journal of oncology.

[54]  Y. Ikehara,et al.  Up-regulation of a set of glycosyltransferase genes in human colorectal cancer. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[55]  Zhao-You Tang,et al.  Elevated activity of N -acetylglucosaminyltransferase V in human hepatocellular carcinoma , 1998, Journal of Cancer Research and Clinical Oncology.

[56]  S. Satomura,et al.  Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis. , 1999, Journal of hepatology.

[57]  R Apweiler,et al.  On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. , 1999, Biochimica et biophysica acta.

[58]  Usefulness of Lens culinaris agglutinin A-reactive fraction of alpha-fetoprotein (AFP-L3) as a marker of distant metastasis from hepatocellular carcinoma. , 1999, Oncology reports.

[59]  R. Poulsom,et al.  An α2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas , 1999 .

[60]  R. Poulsom,et al.  An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas. , 1999, Glycobiology.

[61]  P. Saigo,et al.  Selection of carbohydrate antigens in human epithelial ovarian cancers as targets for immunotherapy: Serous and mucinous tumors exhibit distinctive patterns of expression , 1999, International journal of cancer.

[62]  S. Tsuboi,et al.  Dual roles of sialyl Lewis X oligosaccharides in tumor metastasis and rejection by natural killer cells , 1999, The EMBO journal.

[63]  T. Suda,et al.  Sialyl Tn antigen expression is associated with the prognosis of patients with advanced colorectal cancer. , 1999, Hepato-gastroenterology.

[64]  W. Chaney,et al.  Control of metastasis by Asn-linked, beta1-6 branched oligosaccharides in mouse mammary cancer cells. , 1999, Glycobiology.

[65]  J. Nesland,et al.  Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study. , 2000, Gynecologic oncology.

[66]  J. Nesland,et al.  Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions. , 2000, Human pathology.

[67]  Y. Tagawa,et al.  Expression of Lewis(a), sialyl Lewis(a), Lewis(x) and sialyl Lewis(x) antigens as prognostic factors in patients with colorectal cancer. , 2000, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[68]  P. Schlag,et al.  Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases , 2000, Gut.

[69]  [Surgical treatment of acute diverticulitis of the large intestine]. , 2000, Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti.

[70]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[71]  M. Monden,et al.  Elevated expression of UDP‐N‐acetylglucosamine: αmannoside β1,6 N‐acetylglucosaminyltransferase is an early event in hepatocarcinogenesis , 2001 .

[72]  M. Monden,et al.  Elevated expression of UDP-N-acetylglucosamine: alphamannoside beta1,6 N-acetylglucosaminyltransferase is an early event in hepatocarcinogenesis. , 2001, International journal of cancer.

[73]  M. Ghazizadeh,et al.  Immunohistochemical expression of T, Tn and sialyl-Tn antigens and clinical outcome in human breast carcinoma. , 2001, Anticancer research.

[74]  S. Brooks,et al.  GalNAc glycoprotein expression by breast cell lines, primary breast cancer and normal breast epithelial membrane , 2001, British Journal of Cancer.

[75]  F. Real,et al.  Differential Distribution of Sialic Acid in α2,3 and α2,6 Linkages in the Apical Membrane of Cultured Epithelial Cells and Tissues , 2001 .

[76]  S. Satomura,et al.  AFP-L3: a new generation of tumor marker for hepatocellular carcinoma. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[77]  E. Pocheć,et al.  Comparison of the lectin-binding pattern in different human melanoma cell lines , 2001, Melanoma research.

[78]  Ying Zhang,et al.  Relationship between metastasis-associated phenotypes and N-glycan structure of surface glycoproteins in human hepatocarcinoma cells , 2001, Journal of Cancer Research and Clinical Oncology.

[79]  T. Nagayasu,et al.  Expression of ABH/Lewis-related antigens as prognostic factors in patients with breast cancer , 2002, Journal of Cancer Research and Clinical Oncology.

[80]  D. Fishman,et al.  The scientific basis of early detection of epithelial ovarian cancer: the National Ovarian Cancer Early Detection Program (NOCEDP). , 2002, Cancer treatment and research.

[81]  S. Akiyama,et al.  Aberrant N-Glycosylation of β1 Integrin Causes Reduced α5β1 Integrin Clustering and Stimulates Cell Migration , 2002 .

[82]  J. Boyd,et al.  Current understanding of the epidemiology and clinical implications of BRCA1 and BRCA2 mutations for ovarian cancer , 2002, Current opinion in obstetrics & gynecology.

[83]  P. Schlag,et al.  Cell surface α2,6-sialylation affects adhesion of breast carcinoma cells , 2002 .

[84]  Anna Laskowska,et al.  Sialyl Lewis(a): a tumor-associated carbohydrate antigen involved in adhesion and metastatic potential of cancer cells. , 2002, Acta biochimica Polonica.

[85]  P. Schlag,et al.  Cell surface alpha 2,6 sialylation affects adhesion of breast carcinoma cells. , 2002, Experimental cell research.

[86]  M. Fiorentino,et al.  Expression of β-galactoside α2,6 sialyltransferase and of α2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis , 2003 .

[87]  L. Hornez,et al.  Prognostic value of tumoral sialyltransferase expression and circulating E-selectin concentrations in node-negative breast cancer patients. , 2003, The International journal of biological markers.

[88]  J. Lowe,et al.  Fucose: biosynthesis and biological function in mammals. , 2003, Glycobiology.

[89]  Mark Sutton-Smith,et al.  Characterization of the Oligosaccharides Associated with the Human Ovarian Tumor Marker CA125* , 2003, Journal of Biological Chemistry.

[90]  M. Hanski,et al.  Fucosyltransferase III and sialyl-Lex expression correlate in cultured colon carcinoma cells but not in colon carcinoma tissue , 1996, Glycoconjugate Journal.

[91]  Naoyuki Taniguchi,et al.  Addition of beta1-6 GlcNAc branching to the oligosaccharide attached to Asn 772 in the serine protease domain of matriptase plays a pivotal role in its stability and resistance against trypsin. , 2003, Glycobiology.

[92]  T. Nagayasu,et al.  Differences in prognosis of colorectal cancer patients based on the expression of sialyl Lewisa, sialyl Lewisx and sialyl Tn antigens in serum and tumor tissue. , 2004, Anticancer research.

[93]  V. Gouyer,et al.  Expression of Sialyl-Tn antigen in breast cancer cells transfected with the human CMP-Neu5Ac: GalNAc α2,6-sialyltransferase (ST6GalNAc I) cDNA , 2001, Glycoconjugate Journal.

[94]  M. Lacroix,et al.  Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update , 2004, Breast Cancer Research and Treatment.

[95]  K. Cooper,et al.  Factors associated with cytoreducibility among women with ovarian carcinoma. , 2004, Gynecologic oncology.

[96]  M. Reddish,et al.  Different modes of sialyl-Tn expression during malignant transformation of human colonic mucosa , 2004, Glycoconjugate Journal.

[97]  F. dall’Olio The sialyl-α2,6-lactosaminyl-structure: Biosynthesis and functional role , 2000, Glycoconjugate Journal.

[98]  D. Hoja-Łukowicz,et al.  N-glycoproteins bearing &bgr;1–6 branched oligosaccharides from the A375 human melanoma cell line analysed by tandem mass spectrometry , 2004, Melanoma research.

[99]  I. Ellis,et al.  High expression of Lewisy/b antigens is associated with decreased survival in lymph node negative breast carcinomas , 2005, Breast Cancer Research.

[100]  Peng-Hui Wang,et al.  Altered mRNA expressions of sialyltransferases in ovarian cancers. , 2005, Gynecologic oncology.

[101]  H. Sakahara,et al.  Expression of sialosyl-Tn antigen (monoclonal antibody MLS102 reactive) in normal tissues and malignant tumors of the digestive tract , 2005, Journal of Cancer Research and Clinical Oncology.

[102]  P. Vasey,et al.  Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 Trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[103]  E. Pocheć,et al.  Characterization of glycosylation and adherent properties of melanoma cell lines , 2005, Cancer Immunology, Immunotherapy.

[104]  C. Bertozzi,et al.  Glycans in cancer and inflammation — potential for therapeutics and diagnostics , 2005, Nature Reviews Drug Discovery.

[105]  D. Rimm,et al.  Coexpression of β1,6-N-Acetylglucosaminyltransferase V Glycoprotein Substrates Defines Aggressive Breast Cancers with Poor Outcome , 2005, Cancer Epidemiology Biomarkers & Prevention.

[106]  M. Butler,et al.  Optimisation of the Cellular Metabolism of Glycosylation for Recombinant Proteins Produced by Mammalian Cell Systems , 2006, Cytotechnology.

[107]  U. Jeschke,et al.  Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis. , 2005, Anticancer research.

[108]  Peng-Hui Wang,et al.  Altered Glycosylation in Cancer: Sialic Acids and Sialyltransferases , 2005 .

[109]  Robert Camp,et al.  β1,6-Branched Oligosaccharides Are Increased in Lymph Node Metastases and Predict Poor Outcome in Breast Carcinoma , 2005, Clinical Cancer Research.

[110]  N. Ohuchi,et al.  Expression of L-PHA-binding proteins in breast cancer: Reconstitution and molecular characterization of β1–6 branched oligosaccharides in three-dimensional cell culture , 2005, Breast Cancer Research and Treatment.

[111]  I. Ishiwata,et al.  Alterations in the glycolipid composition and cellular properties of ovarian carcinoma‐derived RMG‐1 cells on transfection of the α1,2‐fucosyltransferase gene , 2005, Cancer science.

[112]  L. Suva,et al.  Characterization of the glycosylation profile of the human breast cancer cell line, MDA-231, and a bone colonizing variant. , 2006, International journal of oncology.

[113]  P. Altevogt,et al.  Different expression levels of alpha3/4 fucosyltransferases and Lewis determinants in ovarian carcinoma tissues and cell lines. , 2006, International journal of oncology.

[114]  G. Soma,et al.  Expression of Tn and sialyl-Tn antigens in endometrial cancer: its relationship with tumor-produced cyclooxygenase-2, tumor-infiltrated lymphocytes and patient prognosis. , 2006, Anticancer research.

[115]  D. Alberts,et al.  Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer. , 2006, Gynecologic oncology.

[116]  S. Bhoola,et al.  Diagnosis and Management of Epithelial Ovarian Cancer , 2006, Obstetrics and gynecology.

[117]  R. Ozols Systemic therapy for ovarian cancer: current status and new treatments. , 2006, Seminars in oncology.

[118]  M. Friedlander,et al.  Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer , 2006, International Journal of Gynecologic Cancer.

[119]  Maureen E. Taylor,et al.  Lewis x Antigen Mediates Adhesion of Human Breast Carcinoma Cells to Activated Endothelium. Possible Involvement of the Endothelial Scavenger Receptor C-type Lectin , 2006, Breast Cancer Research and Treatment.

[120]  Wen-Lin Kuo,et al.  A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.

[121]  H. El‐Serag,et al.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.

[122]  Lloyd M. Smith,et al.  Analysis of cell surface carbohydrate expression patterns in normal and tumorigenic human breast cell lines using lectin arrays. , 2007, Analytical chemistry.

[123]  D. Santini,et al.  Biosynthesis and expression of the Sda and sialyl Lewis x antigens in normal and cancer colon. , 2007, Glycobiology.

[124]  R. Berkowitz,et al.  Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal Relationship , 2007, The American journal of surgical pathology.

[125]  Branched Oiigosaccharides as a Marker of Tumor Progression in Human Breast and Colon Neoplasia , 2007 .

[126]  M. Pierce,et al.  Inhibition of a Specific N-Glycosylation Activity Results in Attenuation of Breast Carcinoma Cell Invasiveness-related Phenotypes , 2007, Journal of Biological Chemistry.

[127]  E. Pocheć,et al.  Identification of proteins bearing beta1-6 branched N-glycans in human melanoma cell lines from different progression stages by tandem mass spectrometry analysis. , 2007, Biochimica et biophysica acta.

[128]  S. Ferrone,et al.  Characterization of WiDr: A human colon carcinoma cell line , 1979, In Vitro.

[129]  Hermann Brenner,et al.  Blood Markers for Early Detection of Colorectal Cancer: A Systematic Review , 2007, Cancer Epidemiology Biomarkers & Prevention.

[130]  Kit S. Lam,et al.  A Serum Glycomics Approach to Breast Cancer Biomarkers*S , 2007, Molecular & Cellular Proteomics.

[131]  J. Garber,et al.  A candidate precursor to serous carcinoma that originates in the distal fallopian tube , 2007 .

[132]  H. Yoo,et al.  Functional Proteomics Study Reveals That N-Acetylglucosaminyltransferase V Reinforces the Invasive/Metastatic Potential of Colon Cancer through Aberrant Glycosylation on Tissue Inhibitor of Metalloproteinase-1*S , 2008, Molecular & Cellular Proteomics.

[133]  R. Drapkin,et al.  Serous Carcinogenesis in the Fallopian Tube: A Descriptive Classification , 2008, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[134]  A. Amoresano,et al.  Characterisation of alpha3beta1 and alpha(v)beta3 integrin N-oligosaccharides in metastatic melanoma WM9 and WM239 cell lines. , 2008, Biochimica et biophysica acta.

[135]  N. Taniguchi Toward Cancer Biomarker Discovery using the Glycomics Approach , 2008, Proteomics.

[136]  S. Bellis,et al.  ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function , 2008, Journal of ovarian research.

[137]  D. Dinulescu,et al.  Focused glycomic analysis of the N‐linked glycan biosynthetic pathway in ovarian cancer , 2008, Proteomics.

[138]  E. Kohn,et al.  Ovarian cancer in the proteomics era , 2008, International Journal of Gynecologic Cancer.

[139]  Joris R Delanghe,et al.  Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[140]  Naoyuki Taniguchi,et al.  Functional roles of N‐glycans in cell signaling and cell adhesion in cancer , 2008, Cancer science.

[141]  Feng Su,et al.  The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125? , 2008, American journal of obstetrics and gynecology.

[142]  K. Aoki,et al.  Targeted glycoproteomic identification of biomarkers for human breast carcinoma. , 2008, Journal of proteome research.

[143]  T. Nakagawa,et al.  Biological function of fucosylation in cancer biology. , 2007, Journal of biochemistry.

[144]  A. M. Wu,et al.  Lectins as tools in glycoconjugate research , 2009, Glycoconjugate Journal.

[145]  Yehia Mechref,et al.  Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles. , 2008, Clinical chemistry.

[146]  Pauline M Rudd,et al.  A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression. , 2008, Glycobiology.

[147]  Y. Li,et al.  Lectin microarrays identify cell-specific and functionally significant cell surface glycan markers. , 2008, Glycobiology.

[148]  R. Sainger,et al.  Clinical usefulness of alterations in sialic acid, sialyl transferase and sialoproteins in breast cancer , 2004, Indian Journal of Clinical Biochemistry.

[149]  J. Gu,et al.  N‐acetylglucosaminyltransferase III expression is regulated by cell‐cell adhesion via the E‐cadherin–catenin–actin complex , 2008, Proteomics.

[150]  K. Khoo,et al.  Highly fucosylated N-glycan ligands for mannan-binding protein expressed specifically on CD26 (DPPVI) isolated from a human colorectal carcinoma cell line, SW1116. , 2008, Glycobiology.

[151]  M. Ohue,et al.  Comprehensive clinico-glycomic study of 16 colorectal cancer specimens: elucidation of aberrant glycosylation and its mechanistic causes in colorectal cancer cells. , 2009, Journal of proteome research.

[152]  Yin-kun Liu,et al.  Lectin‐based glycoproteomics to explore and analyze hepatocellular carcinoma‐related glycoprotein markers , 2009, Electrophoresis.

[153]  J. Michalski,et al.  Expression of a core 3 disialyl-Le(x) hexasaccharide in human colorectal cancers: a potential marker of malignant transformation in colon. , 2009, Journal of proteome research.

[154]  G. Hansson,et al.  A complex, but uniform O-glycosylation of the human MUC2 mucin from colonic biopsies analyzed by nanoLC/MSn. , 2009, Glycobiology.

[155]  C. Van Steenkiste,et al.  Alteration of protein glycosylation in liver diseases. , 2009, Journal of hepatology.

[156]  K. Kato,et al.  Contribution of sialidase NEU1 to suppression of metastasis of human colon cancer cells through desialylation of integrin β4 , 2009, Oncogene.

[157]  J. Gu,et al.  Core fucosylation of E‐cadherin enhances cell–cell adhesion in human colon carcinoma WiDr cells , 2009, Cancer science.

[158]  Maria Blomqvist,et al.  Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens. , 2009, Cancer research.

[159]  Lai-Xi Wang,et al.  Enhanced immune recognition of cryptic glycan markers in human tumors. , 2009, Cancer research.

[160]  G. Wiederschain,et al.  Essentials of glycobiology , 2009, Biochemistry (Moscow).

[161]  P. Stanley,et al.  Glycomics Profiling of Chinese Hamster Ovary Cell Glycosylation Mutants Reveals N-Glycans of a Novel Size and Complexity* , 2009, The Journal of Biological Chemistry.

[162]  D. Goldstein,et al.  Proteogenomic studies in epithelial ovarian cancer: established knowledge and future needs. , 2009, Biomarkers in medicine.

[163]  Nigel C Bird,et al.  The role of cell adhesion molecules in the progression of colorectal cancer and the development of liver metastasis. , 2009, Cellular signalling.

[164]  Tara L. Kieffer,et al.  Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis , 2009 .

[165]  A. Tomassetti,et al.  E-cadherin directly contributes to PI3K/AKT activation by engaging the PI3K-p85 regulatory subunit to adherens junctions of ovarian carcinoma cells , 2009, Oncogene.

[166]  John D. Minna,et al.  Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery , 2009, PloS one.

[167]  Wenqiang Song,et al.  N-Acetylgalactosaminyltransferase-14 as a potential biomarker for breast cancer by immunohistochemistry , 2010, BMC Cancer.

[168]  Joseph Zaia,et al.  Mass spectrometry and glycomics. , 2010, Omics : a journal of integrative biology.

[169]  J. Marrero,et al.  Recent advances in the treatment of hepatocellular carcinoma , 2010, Current opinion in gastroenterology.

[170]  T. Nagy,et al.  Specific posttranslational modification regulates early events in mammary carcinoma formation , 2010, Proceedings of the National Academy of Sciences.

[171]  Yehia Mechref,et al.  Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer-biomarker discovery. , 2010, Analytical chemistry.

[172]  Ningombam Sanjib Meitei,et al.  Bioinformatics in glycomics: glycan characterization with mass spectrometric data using SimGlycan. , 2010, Methods in molecular biology.

[173]  Scott R. Kronewitter,et al.  High-Mannose Glycans are Elevated during Breast Cancer Progression* , 2010, Molecular & Cellular Proteomics.

[174]  Daniel Kolarich,et al.  GlycoSpectrumScan: fishing glycopeptides from MS spectra of protease digests of human colostrum sIgA. , 2010, Journal of proteome research.

[175]  Li Fei-Fei,et al.  Lewis(y) antigen stimulates the growth of ovarian cancer cells via regulation of the epidermal growth factor receptor pathway. , 2010, Oncology reports.

[176]  T. Sørlie,et al.  Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression , 2010, Molecular oncology.

[177]  L. Wells,et al.  Identification of candidate biomarkers with cancer‐specific glycosylation in the tissue and serum of endometrioid ovarian cancer patients by glycoproteomic analysis , 2010, Proteomics.

[178]  M. Herlyn,et al.  What is a good model for melanoma? , 2010, The Journal of investigative dermatology.

[179]  Peter W. Laird,et al.  DNA Methylation Profiles of Ovarian Epithelial Carcinoma Tumors and Cell Lines , 2010, PloS one.

[180]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[181]  J. Reuben,et al.  Levels of specific serum N-glycans identify breast cancer patients with higher circulating tumor cell counts. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[182]  L. Yue,et al.  Differential expression of the α2,3-sialic acid residues in breast cancer is associated with metastatic potential. , 2011, Oncology reports.

[183]  Nan Li,et al.  Caco-2 and LS174T cell lines provide different models for studying mucin expression in colon cancer. , 2011, Tissue & cell.

[184]  G. Siegal,et al.  The emerging importance of α-L-fucose in human breast cancer: a review. , 2011, American journal of translational research.

[185]  Armin Ruf,et al.  Unique carbohydrate–carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose , 2011, Proceedings of the National Academy of Sciences.

[186]  Chunjing Zhang,et al.  The Effect of Overexpression of α (1, 3)- FucosyltransferaseVII on Adhesive Capability of Human Colon Carcinoma HT-29 Cells to HUVECs , 2011 .

[187]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[188]  D. Santini,et al.  The biosynthesis of the selectin-ligand sialyl Lewis x in colorectal cancer tissues is regulated by fucosyltransferase VI and can be inhibited by an RNA interference-based approach. , 2011, The international journal of biochemistry & cell biology.

[189]  P. Rudd,et al.  5-AZA-2'-deoxycytidine induced demethylation influences N-glycosylation of secreted glycoproteins in ovarian cancer , 2011, Epigenetics.

[190]  Chien-Yu Chen,et al.  Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells , 2011, Proceedings of the National Academy of Sciences.

[191]  A. Ido,et al.  Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease. , 2011, Oncology reports.

[192]  A. Tutt,et al.  Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers. , 2011, Cancer research.

[193]  M. Johansson,et al.  Altered O‐glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation , 2011, Inflammatory bowel diseases.

[194]  P. Altevogt,et al.  N-Glycosylation of total cellular glycoproteins from the human ovarian carcinoma SKOV3 cell line and of recombinantly expressed human erythropoietin. , 2011, Glycobiology.

[195]  Mary Ann Comunale,et al.  Increased Levels of Tetra-antennary N-Linked Glycan but Not Core Fucosylation Are Associated with Hepatocellular Carcinoma Tissue , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[196]  Michael P. Cusack,et al.  Lectin chromatography/mass spectrometry discovery workflow identifies putative biomarkers of aggressive breast cancers. , 2012, Journal of proteome research.

[197]  L. McDonnell,et al.  N-glycosylation of Colorectal Cancer Tissues , 2012, Molecular & Cellular Proteomics.

[198]  L. Wells,et al.  Developmental Expression of the Neuron-specific N-Acetylglucosaminyltransferase Vb (GnT-Vb/IX) and Identification of Its in Vivo Glycan Products in Comparison with Those of Its Paralog, GnT-V* , 2012, The Journal of Biological Chemistry.

[199]  Aberrantly glycosylated MUC1 is expressed on the surface of breast cancer cells and a target for antibody-dependent cell-mediated cytotoxicity , 2013, Glycoconjugate Journal.

[200]  Pauline M Rudd,et al.  Glycans as cancer biomarkers. , 2012, Biochimica et biophysica acta.

[201]  T. Fujii,et al.  Associated expression of α2,3sialylated type 2 chain structures with lymph node metastasis in distal colorectal cancer , 2013, Surgery Today.

[202]  Pamela Greenwell,et al.  The lectin Helix pomatia agglutinin recognizes O-GlcNAc containing glycoproteins in human breast cancer. , 2012, Glycobiology.

[203]  Lijuan Hu,et al.  The role of N-acetylglucosaminyltransferases V in the malignancy of human hepatocellular carcinoma. , 2012, Experimental and molecular pathology.

[204]  J. Bergquist,et al.  L1CAM from human melanoma carries a novel type of N-glycan with Galβ1-4Galβ1- motif. Involvement of N-linked glycans in migratory and invasive behaviour of melanoma cells , 2012, Glycoconjugate Journal.

[205]  W. Alley,et al.  N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients. , 2012, Journal of proteome research.

[206]  T. Yen,et al.  Glycoprotein profiles of human breast cells demonstrate a clear clustering of normal/benign versus malignant cell lines and basal versus luminal cell lines. , 2012, Journal of proteome research.

[207]  M. Vuskovic,et al.  Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array , 2012, International journal of cancer.

[208]  K. Khoo,et al.  Priming mass spectrometry-based sulfoglycomic mapping for identification of terminal sulfated lacdiNAc glycotope , 2012, Glycoconjugate Journal.

[209]  J. Ko,et al.  Overexpression and β-1,6-N-Acetylglucosaminylation-initiated Aberrant Glycosylation of TIMP-1 , 2012, The Journal of Biological Chemistry.

[210]  Jean-Pierre Gillet,et al.  The clinical relevance of cancer cell lines. , 2013, Journal of the National Cancer Institute.

[211]  Jun-Tao Ji,et al.  Expression of alpha 1,6-fucosyltransferase 8 in hepatitis B virus-related hepatocellular carcinoma influences tumour progression. , 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[212]  C. Sessa,et al.  Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[213]  M. Morimoto,et al.  Fucosylated fraction of alpha-fetoprotein as a serological marker of early hepatocellular carcinoma. , 2013, Anticancer research.

[214]  Jiayin Yang,et al.  Relevant markers of cancer stem cells indicate a poor prognosis in hepatocellular carcinoma patients: a meta-analysis , 2013, European journal of gastroenterology & hepatology.

[215]  A. Villanueva,et al.  Management of small hepatocellular carcinoma in cirrhosis: focus on portal hypertension. , 2013, World journal of gastroenterology.